TD Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Sell |
1,602
-209
| -12% | -$50.4K | ﹤0.01% | 1147 |
|
|
2025
Q1 | $441K | Buy |
1,811
+182
| +11% | +$44.3K | ﹤0.01% | 1155 |
|
|
2024
Q4 | $535K | Buy |
1,629
+280
| +21% | +$92K | ﹤0.01% | 1180 |
|
|
2024
Q3 | $448K | Sell |
1,349
-4,001
| -75% | -$1.33M | ﹤0.01% | 1311 |
|
|
2024
Q2 | $1.46M | Sell |
5,350
-26
| -0.5% | -$7.1K | ﹤0.01% | 1083 |
|
|
2024
Q1 | $1.86M | Sell |
5,376
-129
| -2% | -$44.6K | ﹤0.01% | 1050 |
|
|
2023
Q4 | $1.78M | Buy |
5,505
+431
| +8% | +$139K | ﹤0.01% | 1046 |
|
|
2023
Q3 | $1.82M | Sell |
5,074
-340
| -6% | -$122K | ﹤0.01% | 983 |
|
|
2023
Q2 | $2.05M | Buy |
5,414
+257
| +5% | +$97.4K | ﹤0.01% | 960 |
|
|
2023
Q1 | $2.47M | Sell |
5,157
-73
| -1% | -$35K | ﹤0.01% | 919 |
|
|
2022
Q4 | $2.2M | Buy |
5,230
+64
| +1% | +$26.9K | ﹤0.01% | 953 |
|
|
2022
Q3 | $2.16M | Sell |
5,166
-60
| -1% | -$25.1K | ﹤0.01% | 978 |
|
|
2022
Q2 | $2.59M | Sell |
5,226
-1,945
| -27% | -$963K | ﹤0.01% | 931 |
|
|
2022
Q1 | $4.04M | Buy |
7,171
+171
| +2% | +$96.3K | ﹤0.01% | 875 |
|
|
2021
Q4 | $5.29M | Sell |
7,000
-358
| -5% | -$270K | ﹤0.01% | 859 |
|
|
2021
Q3 | $5.49M | Sell |
7,358
-177
| -2% | -$132K | 0.01% | 797 |
|
|
2021
Q2 | $5.57M | Buy |
7,535
+146
| +2% | +$108K | 0.01% | 803 |
|
|
2021
Q1 | $4.22M | Sell |
7,389
-2
| -0% | -$1.14K | ﹤0.01% | 878 |
|
|
2020
Q4 | $4.31M | Buy |
7,391
+224
| +3% | +$131K | 0.01% | 831 |
|
|
2020
Q3 | $3.69M | Buy |
7,167
+2,220
| +45% | +$1.14M | 0.01% | 784 |
|
|
2020
Q2 | $2.23M | Buy |
+4,947
| New | +$2.23M | ﹤0.01% | 851 |
|
|
2016
Q4 | – | Sell |
-12,800
| Closed | -$2.1M | – | 1370 |
|
|
2016
Q3 | $2.1M | Buy |
12,800
+2,100
| +20% | +$344K | ﹤0.01% | 868 |
|
|
2016
Q2 | $1.53M | Buy |
+10,700
| New | +$1.53M | ﹤0.01% | 899 |
|